ArticleInternational journal of impotence research2024

Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort study.

Emil Durukan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.